Learnings from real-life experience of using omalizumab for chronic urticaria in Latin America

BACKGROUND: Updated urticaria guidelines recommend that patients should be assessed for disease activity, severity, control, and quality of life at baseline and follow up. Regarding treatment, guidelines consider second generation antihistamines as the cornerstone in therapy for chronic urticaria (C...

Descripción completa

Detalles Bibliográficos
Autores principales: Cherrez-Ojeda, Ivan, Maurer, Marcus, Bernstein, Jonathan A., Vanegas, Emanuel, Felix, Miguel, Ramon, German D., Ensina, Luis Felipe, Larco Sousa, José Ignacio, Matos Benavides, Edgar Emilio, Cardona Villa, R., Latour Staffeld, P., Morfin-Maciel, Blanca María, Mori, Jose, Wilches C, Paul, Mata, Valeria L., Cherrez, Annia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: World Allergy Organization 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6439401/
https://www.ncbi.nlm.nih.gov/pubmed/30937137
http://dx.doi.org/10.1016/j.waojou.2019.100011

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6439401/
https://www.ncbi.nlm.nih.gov/pubmed/30937137
http://dx.doi.org/10.1016/j.waojou.2019.100011

Ejemplares similares